Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cardiac Ablation Devices Pipeline Products Market Report Overview

Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The Cardiac Ablation Devices pipeline market research report provides comprehensive information about the Cardiac Ablation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Ablation Devices Pipeline Products Market Segmentation by Territories

The key territories with products in the pipeline are the US, China, Europe, Canada, Australia, the Czech Republic, South Korea, and Germany. As of February 2023, the US has the highest number of products in the pipeline out of them all.

Cardiac Ablation Devices Pipeline Products Market Analysis, by Territories, 2023 (%)

Cardiac Ablation Devices Pipeline Products Market Analysis, by Territories, 2023 (%)

For more territory insights into the Cardiac Ablation Devices pipeline products market, download a free report sample

Cardiac Ablation Devices Pipeline Products Market Segmentation by Regulatory Paths

The key regulatory paths followed by the Cardiac Ablation Devices pipeline products market are PMA, NMPA, 510(k), CE, MDL, MDITAC, and TGA. Most of the products follow the PMA pathway to enter the market.

Cardiac Ablation Devices Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

For more Cardiac Ablation Devices pipeline products regulatory path insights, download a free report sample

 

For more Cardiac Ablation Devices pipeline products regulatory path insights, download a free report sample

Cardiac Ablation Devices Pipeline Products Market - Competitive Landscape

Some of the leading companies in the Cardiac Ablation Devices pipeline products market are AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Affera Inc, AFreeze GmbH, AngioDynamics Inc, APT Medical Inc, Arga Medtech SA, and Atrian Medical Ltd.

Acutus Medical Inc (Acutus Medical): Headquartered in Carlsbad, California, USA, Acutus Medical is engaged in providing electrophysiological mapping systems for the treatment of cardiac arrhythmias. Acutus Medical’s electrofunctional mapping systems provides solutions to diagnose and treat atrial fibrillation. The company products enable physicians to visualize CT-quality scan, map real-time dipole density, and identify infected locations causing arrhythmia.

Adagio Medical Inc.: Headquartered in Laguna Hills, California, USA, Adagio Medical is a medical device company that develops innovative cryoablation technologies that create continuous, transmural lesions to treat cardiac arrhythmias.

Affera Inc (Affera): Headquartered in Watertown, Massachusetts, USA, Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.

For more company insights into the Cardiac Ablation Devices pipeline products market, download a free report sample

Cardiac Ablation Devices Pipeline Products Market Report Overview

Key Territories The US, China, Europe, Canada, Australia, the Czech Republic, South Korea, and Germany
Key Regulatory Paths PMA, NMPA, 510(k), CE, MDL, MDITAC, and TGA
Leading Companies AblaCor Medical Corporation, AccuPulse Medical Technology Co Ltd, Acutus Medical Inc, Adagio Medical Inc., Affera Inc, AFreeze GmbH, AngioDynamics Inc, APT Medical Inc, Arga Medtech SA, and Atrian Medical Ltd

Scope

This report provides:

  • Extensive coverage of the cardiac ablation devices under development
  • Reviews of details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of cardiac ablation devices and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • Key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

AblaCor Medical Corporation
AccuPulse Medical Technology Co Ltd
Acutus Medical Inc
Adagio Medical Inc.
Affera Inc
AFreeze GmbH
AngioDynamics Inc
APT Medical Inc
Arga Medtech SA
Atrian Medical Ltd
AtriCure Inc
Axon Therapies Inc
Baylis Medical Company Inc
Biosense Webster Inc
Corfigo Inc
Coridea, LLC
CPSI Biotech
Cryofocus Medtech Shanghai Co Ltd
Epiendoaf Inc
Farapulse Inc
Galaxy Medical Products Inc
Hadassah Medical Center
Hangzhou Nuocheng Medical Technology Co Ltd
Hangzhou Nuomao Medical Technology Co Ltd
Helical Solutions, Inc. (Inactive)
Huifeng Biotechnology (Shanghai) Co Ltd
Insight Lifetech Co Ltd
Japan Lifeline Co Ltd
Johns Hopkins University
Kardium Inc
LuxCath, LLC
Medtronic Plc
National Science and Technology Development Agency
Northwestern University
Pavmed Inc
Shanghai Antec Medical Technology Co Ltd
Shanghai HeartCare Medical Technology Co Ltd
Shanghai Keku Medical Technology Co Ltd
Shanghai Weiqi Medical Equipment Co Ltd
Shanghai Xuanyu Medical Equipment Co Ltd
Sichuan Jinjiang Electronic Science and Technology Co Ltd
Spectranetics Corp
Suzhou Aikemai Medical Technology Co Ltd
Tau Pnu Medical Co., Ltd.
The Chaim Sheba Medical Center
Thermedical Inc
Tianjin Intelligent Health Medical Co Ltd
Toray Medical Co Ltd
Tufts Medical Center
University of California Los Angeles
University of Chicago
University of Iowa
Varian Medical Systems Inc
Virginia Polytechnic Institute and State University
VytronUS Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 12

2 Introduction 13

2.1 Cardiac Ablation Devices Overview 13

3 Products under Development 14

3.1 Cardiac Ablation Devices – Pipeline Products by Stage of Development 14

3.2 Cardiac Ablation Devices – Pipeline Products by Territory 15

3.3 Cardiac Ablation Devices – Pipeline Products by Regulatory Path 16

3.4 Cardiac Ablation Devices – Pipeline Products by Estimated Approval Date 17

3.5 Cardiac Ablation Devices – Ongoing Clinical Trials 18

4 Cardiac Ablation Devices – Pipeline Products under Development by Companies 19

4.1 Cardiac Ablation Devices Companies – Pipeline Products by Stage of Development 19

4.2 Cardiac Ablation Devices – Pipeline Products by Stage of Development 22

5 Cardiac Ablation Devices Companies and Product Overview 25

5.1 AblaCor Medical Corporation Company Overview 25

5.1.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25

5.2 AccuPulse Medical Technology Co Ltd Company Overview 27

5.2.1 AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.3 Acutus Medical Inc Company Overview 28

5.3.1 Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.4 Adagio Medical Inc. Company Overview 31

5.4.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31

5.5 Affera Inc Company Overview 37

5.5.1 Affera Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.6 AFreeze GmbH Company Overview 44

5.6.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 44

5.7 AngioDynamics Inc Company Overview 45

5.7.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.8 APT Medical Inc Company Overview 46

5.8.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46

5.9 Arga Medtech SA Company Overview 48

5.9.1 Arga Medtech SA Pipeline Products & Ongoing Clinical Trials Overview 48

5.10 Atrian Medical Ltd Company Overview 52

5.10.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.11 AtriCure Inc Company Overview 55

5.11.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.12 Axon Therapies Inc Company Overview 59

5.12.1 Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.13 Baylis Medical Company Inc Company Overview 62

5.13.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.14 Biosense Webster Inc Company Overview 63

5.14.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.15 Corfigo Inc Company Overview 66

5.15.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.16 Coridea, LLC Company Overview 67

5.16.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview 67

5.17 CPSI Biotech Company Overview 68

5.17.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview 68

5.18 Cryofocus Medtech Shanghai Co Ltd Company Overview 72

5.18.1 Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 72

5.19 Epiendoaf Inc Company Overview 75

5.19.1 Epiendoaf Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.20 Farapulse Inc Company Overview 76

5.20.1 Farapulse Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.21 Galaxy Medical Products Inc Company Overview 85

5.21.1 Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.22 Hadassah Medical Center Company Overview 88

5.22.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 88

5.23 Hangzhou Nuocheng Medical Technology Co Ltd Company Overview 89

5.23.1 Hangzhou Nuocheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 89

5.24 Hangzhou Nuomao Medical Technology Co Ltd Company Overview 90

5.24.1 Hangzhou Nuomao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.25 Helical Solutions, Inc. (Inactive) Company Overview 93

5.25.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93

5.26 Huifeng Biotechnology (Shanghai) Co Ltd Company Overview 94

5.26.1 Huifeng Biotechnology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 94

5.27 Insight Lifetech Co Ltd Company Overview 95

5.27.1 Insight Lifetech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

5.28 Japan Lifeline Co Ltd Company Overview 97

5.28.1 Japan Lifeline Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

5.29 Johns Hopkins University Company Overview 98

5.29.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 98

5.30 Kardium Inc Company Overview 99

5.30.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.31 LuxCath, LLC Company Overview 106

5.31.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview 106

5.32 Medtronic Plc Company Overview 107

5.32.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 107

5.33 National Science and Technology Development Agency Company Overview 112

5.33.1 National Science and Technology Development Agency Pipeline Products & Ongoing Clinical Trials Overview 112

5.34 Northwestern University Company Overview 113

5.34.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 113

5.35 Pavmed Inc Company Overview 114

5.35.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.36 Shanghai Antec Medical Technology Co Ltd Company Overview 116

5.36.1 Shanghai Antec Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 116

5.37 Shanghai HeartCare Medical Technology Co Ltd Company Overview 118

5.37.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 118

5.38 Shanghai Keku Medical Technology Co Ltd Company Overview 119

5.38.1 Shanghai Keku Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

5.39 Shanghai Weiqi Medical Equipment Co Ltd Company Overview 120

5.39.1 Shanghai Weiqi Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 120

5.40 Shanghai Xuanyu Medical Equipment Co Ltd Company Overview 123

5.40.1 Shanghai Xuanyu Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 123

5.41 Sichuan Jinjiang Electronic Science and Technology Co Ltd Company Overview 124

5.41.1 Sichuan Jinjiang Electronic Science and Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 124

5.42 Spectranetics Corp Company Overview 125

5.42.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview 125

5.43 Suzhou Aikemai Medical Technology Co Ltd Company Overview 126

5.43.1 Suzhou Aikemai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

5.44 Tau Pnu Medical Co., Ltd. Company Overview 128

5.44.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 128

5.45 The Chaim Sheba Medical Center Company Overview 131

5.45.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 131

5.46 Thermedical Inc Company Overview 132

5.46.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview 132

5.47 Tianjin Intelligent Health Medical Co Ltd Company Overview 136

5.47.1 Tianjin Intelligent Health Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.48 Toray Medical Co Ltd Company Overview 137

5.48.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

5.49 Tufts Medical Center Company Overview 138

5.49.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview 138

5.50 University of California Los Angeles Company Overview 139

5.50.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 139

5.51 University of Chicago Company Overview 140

5.51.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 140

5.52 University of Iowa Company Overview 141

5.52.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 141

5.53 Varian Medical Systems Inc Company Overview 142

5.53.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 142

5.54 Virginia Polytechnic Institute and State University Company Overview 143

5.54.1 Virginia Polytechnic Institute and State University Pipeline Products & Ongoing Clinical Trials Overview 143

5.55 VytronUS Inc Company Overview 144

5.55.1 VytronUS Inc Pipeline Products & Ongoing Clinical Trials Overview 144

6 Cardiac Ablation Devices- Recent Developments 147

6.1 Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president 147

6.2 Jan 30, 2023: Medtronic India appoints Michael Blackwell as Vice President 147

6.3 Dec 20, 2022: AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference 147

6.4 Nov 23, 2022: Medtronic Reports Quarterly Earnings 147

6.5 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 147

6.6 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 153

6.7 Nov 10, 2022: Study finds catheter ablation significantly lowers risk of dementia in patients with atrial fibrillation 153

6.8 Oct 11, 2022: AtriCure to Announce Third Quarter 2022 Financial Results 154

6.9 Sep 07, 2022: Medtronic to appear at September investor conferences 154

6.10 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 154

6.11 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 157

6.12 Aug 16, 2022: AtriCure to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference 159

6.13 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 159

6.14 Aug 02, 2022: AtriCure Reports Second Quarter 2022 Financial Results 160

6.15 Aug 02, 2022: First-in-human trial shows promise for hard-to-treat ventricular tachycardia heart rhythms 161

6.16 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results 162

6.17 Jul 20, 2022: AtriCure to Participate at Upcoming Investor Conferences 163

6.18 Jul 12, 2022: AtriCure to Announce Second Quarter 2022 Financial Results 163

6.19 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 164

6.20 Jun 01, 2022: AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer 164

6.21 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 165

6.22 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 165

6.23 May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results 165

6.24 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 166

6.25 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022 167

6.26 Apr 14, 2022: Leading Quantum Scientist Prineha Narang Appointed to Named Professorship at UCLA 169

6.27 Apr 11, 2022: AtriCure to Announce First Quarter 2022 Financial Results 170

6.28 Mar 31, 2022: Imricor adds 15th site and first in Italy 170

6.29 Mar 09, 2022: Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis 171

7 Appendix 173

7.1 Methodology 173

7.2 About GlobalData 176

7.3 Contact Us 176

7.4 Disclaimer 176

Frequently asked questions

Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Cardiac Ablation Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.